Safety and Efficacy of Ranibizumab in Macular Edema following Retinal Vein Occlusion

Macular edema is the leading cause of visual impairment in patients with retinal vein occlusion. Limited improvements may be obtained with laser photocoagulation or intravitreal triamcinolone. However, according to the data provided by randomized clinical trials, intravitreal injections of ranibizum...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallego-Pinazo, Roberto, Dolz-Marco, Rosa, Marín-Lambíes, Cristina, Díaz-Llopis, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619496/
https://www.ncbi.nlm.nih.gov/pubmed/23650454
http://dx.doi.org/10.4137/OED.S7264
_version_ 1782265489964138496
author Gallego-Pinazo, Roberto
Dolz-Marco, Rosa
Marín-Lambíes, Cristina
Díaz-Llopis, Manuel
author_facet Gallego-Pinazo, Roberto
Dolz-Marco, Rosa
Marín-Lambíes, Cristina
Díaz-Llopis, Manuel
author_sort Gallego-Pinazo, Roberto
collection PubMed
description Macular edema is the leading cause of visual impairment in patients with retinal vein occlusion. Limited improvements may be obtained with laser photocoagulation or intravitreal triamcinolone. However, according to the data provided by randomized clinical trials, intravitreal injections of ranibizumab (Lucentis; Genentech, South San Francisco, CA) constitute a new effective and safe option for the management of these vision-threatening diseases. The aim of the present review is to summarize the clinical evidence of ranibizumab for macular edema due to retinal vein occlusions.
format Online
Article
Text
id pubmed-3619496
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Libertas Academica
record_format MEDLINE/PubMed
spelling pubmed-36194962013-05-06 Safety and Efficacy of Ranibizumab in Macular Edema following Retinal Vein Occlusion Gallego-Pinazo, Roberto Dolz-Marco, Rosa Marín-Lambíes, Cristina Díaz-Llopis, Manuel Ophthalmol Eye Dis Review Macular edema is the leading cause of visual impairment in patients with retinal vein occlusion. Limited improvements may be obtained with laser photocoagulation or intravitreal triamcinolone. However, according to the data provided by randomized clinical trials, intravitreal injections of ranibizumab (Lucentis; Genentech, South San Francisco, CA) constitute a new effective and safe option for the management of these vision-threatening diseases. The aim of the present review is to summarize the clinical evidence of ranibizumab for macular edema due to retinal vein occlusions. Libertas Academica 2012-03-13 /pmc/articles/PMC3619496/ /pubmed/23650454 http://dx.doi.org/10.4137/OED.S7264 Text en © 2012 the author(s), publisher and licensee Libertas Academica Ltd. This is an open access article. Unrestricted non-commercial use is permitted provided the original work is properly cited.
spellingShingle Review
Gallego-Pinazo, Roberto
Dolz-Marco, Rosa
Marín-Lambíes, Cristina
Díaz-Llopis, Manuel
Safety and Efficacy of Ranibizumab in Macular Edema following Retinal Vein Occlusion
title Safety and Efficacy of Ranibizumab in Macular Edema following Retinal Vein Occlusion
title_full Safety and Efficacy of Ranibizumab in Macular Edema following Retinal Vein Occlusion
title_fullStr Safety and Efficacy of Ranibizumab in Macular Edema following Retinal Vein Occlusion
title_full_unstemmed Safety and Efficacy of Ranibizumab in Macular Edema following Retinal Vein Occlusion
title_short Safety and Efficacy of Ranibizumab in Macular Edema following Retinal Vein Occlusion
title_sort safety and efficacy of ranibizumab in macular edema following retinal vein occlusion
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619496/
https://www.ncbi.nlm.nih.gov/pubmed/23650454
http://dx.doi.org/10.4137/OED.S7264
work_keys_str_mv AT gallegopinazoroberto safetyandefficacyofranibizumabinmacularedemafollowingretinalveinocclusion
AT dolzmarcorosa safetyandefficacyofranibizumabinmacularedemafollowingretinalveinocclusion
AT marinlambiescristina safetyandefficacyofranibizumabinmacularedemafollowingretinalveinocclusion
AT diazllopismanuel safetyandefficacyofranibizumabinmacularedemafollowingretinalveinocclusion

Ejemplares similares